At 12:28 IST, the barometer index, the S&P BSE Sensex, was down 224.11 points or 0.30% to 73,453.02. The Nifty 50 index lost 87.80 points or 0.39% to 22,268.50.
The broader market underperformed the frontline indices. The S&P BSE Mid-Cap index declined 1.90% and the S&P BSE Small-Cap index fell 2.93%.
Sellers outnumbered buyers. On the BSE, 562 shares rose and 3,208 shares fell. A total of 93 shares were unchanged.
Derivatives:
The NSE's India VIX, a gauge of the market's expectation of volatility over the near term, rose 0.95% to 14.52. The Nifty 28 March 2024 futures were trading at 22,348.70, at a premium of 80.2 points as compared with the spot at 22,268.50.
The Nifty option chain for the 28 March 2024 expiry showed maximum Call OI of 34.7 lakh contracts at the 23,000 strike price. Maximum Put OI of 45.4 lakh contracts were seen at 21,000 strike price.
Buzzing Index:
The Nifty Realty index declined 2.76% to 904.70. The index rallied 2.29% in past five trading sessions.
Sobha (down 6.6%), Macrotech Developers (down 5.53%), Swan Energy (down 4.99%), Brigade Enterprises (down 4.48%) and Godrej Properties (down 2.95%) declined.
Among the other losers were Oberoi Realty (down 2.18%), DLF (down 1.89%), Mahindra Lifespace Developers (down 1.26%), Phoenix Mills (down 0.74%) and Prestige Estates Projects (down 0.01%).
Stocks in Spotlight:
Sakar Healthcare surged 7.72% after the company's oncology unit has attained EU GMP approval valid for three years from the audit date of 5th March 2024.
Torrent Pharma shed 0.46%. The drug maker informed that the US drug regulator has issued an establishment inspection report (EIR) for the Bileshwarpura facility in Gujarat stating the inspection to be closed.
Ajmera Realty & Infra India slipped 3.91%. The company announced that it has successfully secured credit facilities totaling to Rs 500 crore from Standard Chartered Bank and ICICI Bank for Ajmera Manathan residential project, to partly repay the GCP loan.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
